Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status.

Summary: Throat and neck cancers caused by the Human Papillomavirus (HPV) are on the rise, creating a need for fast, accurate testing methods. Traditionally, doctors require a solid tissue sample to diagnose these cancers, which often involves invasive procedures. This study explored whether a widely used liquid-based test—commonly used for cervical cancer screening—could work just as well on simple needle biopsies of neck tumors. The researchers compared the liquid test against standard tissue analysis in 24 patients. The results were promising: the liquid test was 100% accurate, matching the standard tissue tests perfectly. This suggests that doctors could soon diagnose HPV-related head and neck cancers using a simple needle aspiration, potentially sparing patients from more invasive surgeries solely for diagnosis.